| Style | Citing Format |
|---|---|
| MLA | Sharafian S, et al.. "Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature." Journal of Clinical Immunology, vol. 42, no. 8, 2022, pp. 1618-1621. |
| APA | Sharafian S, Jacomelli G, Tamizifar B, Shahrooei M, Parvaneh N (2022). Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature. Journal of Clinical Immunology, 42(8), 1618-1621. |
| Chicago | Sharafian S, Jacomelli G, Tamizifar B, Shahrooei M, Parvaneh N. "Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature." Journal of Clinical Immunology 42, no. 8 (2022): 1618-1621. |
| Harvard | Sharafian S et al. (2022) 'Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature', Journal of Clinical Immunology, 42(8), pp. 1618-1621. |
| Vancouver | Sharafian S, Jacomelli G, Tamizifar B, Shahrooei M, Parvaneh N. Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature. Journal of Clinical Immunology. 2022;42(8):1618-1621. |
| BibTex | @article{ author = {Sharafian S and Jacomelli G and Tamizifar B and Shahrooei M and Parvaneh N}, title = {Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature}, journal = {Journal of Clinical Immunology}, volume = {42}, number = {8}, pages = {1618-1621}, year = {2022} } |
| RIS | TY - JOUR AU - Sharafian S AU - Jacomelli G AU - Tamizifar B AU - Shahrooei M AU - Parvaneh N TI - Adenosine Deaminase (Ada) Deficiency: Report of Six New Cases and Reappraisal of Cutaneous Hypermelanosis As an Early Feature JO - Journal of Clinical Immunology VL - 42 IS - 8 SP - 1618 EP - 1621 PY - 2022 ER - |